Detailed answers about BIOLUMINUX CLINICAL RESEARCH SOUTHAMPTON LIMITED, including incorporation, status, business activity, and accounts information.
When was BIOLUMINUX CLINICAL RESEARCH SOUTHAMPTON LIMITED founded?
BIOLUMINUX CLINICAL RESEARCH SOUTHAMPTON LIMITED was officially incorporated on 19 March 2024 and is registered under company number 15575230. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BIOLUMINUX CLINICAL RESEARCH SOUTHAMPTON LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of BIOLUMINUX CLINICAL RESEARCH SOUTHAMPTON LIMITED?
BIOLUMINUX CLINICAL RESEARCH SOUTHAMPTON LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BIOLUMINUX CLINICAL RESEARCH SOUTHAMPTON LIMITED do?
BIOLUMINUX CLINICAL RESEARCH SOUTHAMPTON LIMITED operates in the following sector: 72190 - Other research and experimental development on natural sciences and engineering. This provides insight into the company's primary business activity and industry focus.
What is BIOLUMINUX CLINICAL RESEARCH SOUTHAMPTON LIMITED's registered address?
The registered office address of BIOLUMINUX CLINICAL RESEARCH SOUTHAMPTON LIMITED is 14-15 BRUNSWICK PLACE, SOUTHAMPTON, ENGLAND, SO15 2AQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is BIOLUMINUX CLINICAL RESEARCH SOUTHAMPTON LIMITED financially stable?
The most recent accounts for BIOLUMINUX CLINICAL RESEARCH SOUTHAMPTON LIMITED were made up to 31 March 2025, filed as MICRO ENTITY. Next accounts are due by 31 December 2026.